Replikaは、批判やドラマ、社会的な不安なしに友達が欲しいすべての人のために設計された、No.1のAIチャットボットコンパニオンです。有意義な会話を楽しみ、メンタルウェルビーイングを向上させ、あなたと共に学び成長するユニークなAIの友達を作りましょう。24時間365日、サポートと仲間を提供します。
Triptherapyは、感情的なサポートのための無料・匿名・プライベートなAIチャットサービスです。18歳以上のユーザーは24時間いつでも様々なAIコンパニオンと会話し、感情を吐き出し、思考を整理することができます。データは一切保存されず、完全なプライバシーが保証されます。少額の料金でAIが生成したチャットの要約とヒントを受け取ることも可能です。
製品概要
Replika 製品概要
Replikaは、批判やドラマ、社会的な不安なしに友達が欲しいすべての人のために設計された、No.1のAIチャットボットコンパニオンです。有意義な会話を楽しみ、メンタルウェルビーイングを向上させ、あなたと共に学び成長するユニークなAIの友達を作りましょう。24時間365日、サポートと仲間を提供します。
Triptherapy 製品概要
Triptherapyは、感情的なサポートのための無料・匿名・プライベートなAIチャットサービスです。18歳以上のユーザーは24時間いつでも様々なAIコンパニオンと会話し、感情を吐き出し、思考を整理することができます。データは一切保存されず、完全なプライバシーが保証されます。少額の料金でAIが生成したチャットの要約とヒントを受け取ることも可能です。
Detailed feature comparison
| Feature | Replika | Triptherapy |
|---|---|---|
| 主要カテゴリー | メンタルヘルス | メンタルヘルス |
| 追加日 | 2025-09-09 | 2025-10-21 |
| 価格 | フリーミアム | フリーミアム |
| 公式サイト | replika.ai | www.triptherapy.ai |
| 製品タイプ | アプリ | ウェブサイト |
| Performance data | ||
| ユーザー評価 | 未確認 | 未確認 |
| コメント | 0 | 0 |
| 月間訪問数 | 87.4K | 3.5K |
| 月間成長率 | -20.4% | 未確認 |
| お気に入り | 116 | 104 |
| Details | 詳細を見る | 詳細を見る |
Replika vs Triptherapy monthly traffic
Compare Replika and Triptherapy by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the Replika vs Triptherapy monthly traffic comparison, Replika currently shows 87.4K visits and Triptherapy shows 3.5K; Replika has about 25.3 times the visible traffic of Triptherapy, an absolute difference of about 84K visits. This reflects visible reach, not feature quality or paid users.
Only Replika has complete third-party traffic details; Triptherapy uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
Replika monthly traffic:
Latest traffic
Monthly traffic trend
- 2025/9: 115.7K 月間訪問数
- 2026/1: 116.9K 月間訪問数
- 2026/2: 94.8K 月間訪問数
- 2026/3: 101.1K 月間訪問数
- 2026/4: 109.8K 月間訪問数
- 2026/5: 87.4K 月間訪問数
主要地域
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 53.54% | 46.8K |
| 🇦🇿Azerbaijan | 19.45% | 17K |
| 🇳🇱Netherlands | 17.8% | 15.6K |
| 🇻🇳Vietnam | 5.55% | 4.9K |
| 🇰🇼Kuwait | 3.66% | 3.2K |
流入元
| Source type | Percentage | Traffic |
|---|---|---|
| ダイレクト | 90.03% | 78.7K |
| Eメール | 6.82% | 6K |
| 参照元 | 3.15% | 2.8K |
検索キーワード
Triptherapy monthly traffic:
Latest traffic
Usage comparison
Compare the core capabilities of Replika and Triptherapy
Replika Core features
Triptherapy Core features
Use cases
Replika Use cases
Triptherapy Use cases
Best suited roles
Replika Best suited roles
Triptherapy Best suited roles
Replika vs Triptherapy:In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth Replika vs Triptherapy comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. Replika is primarily listed under “メンタルヘルス”, while Triptherapy is primarily listed under “メンタルヘルス”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Product type (Replika: App; Triptherapy: Website); Monthly visits (Replika: 87.4K; Triptherapy: 3.5K); Favorites (Replika: 116; Triptherapy: 104); Website (Replika: replika.ai; Triptherapy: www.triptherapy.ai); Added (Replika: 2025-09-09; Triptherapy: 2025-10-21). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the Replika vs Triptherapy monthly traffic comparison, Replika currently shows 87.4K visits and Triptherapy shows 3.5K; Replika has about 25.3 times the visible traffic of Triptherapy, an absolute difference of about 84K visits. This reflects visible reach, not feature quality or paid users.
Only Replika has complete third-party traffic details; Triptherapy uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Product positioning, use cases, and roles
Replika and Triptherapy currently overlap in shared categories: メンタルヘルス; shared tags: 不安緩和、チャットボット、感情的サポート、メンタルヘルス; shared roles: カスタマーサポート、人事マネージャー、ソーシャルメディアマネージャー. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
Replika's unique categories/tags are 自己啓発、バーチャルコンパニオン、AIコンパニオン、AI関係、対話型AI、孤独、自己成長、バーチャルフレンド; Triptherapy's are 個人のウェルビーイング、AIセラピー、匿名チャット、ストレス管理. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
Replika has no verified rating, 0 comments, 116 favorites, and 120 likes;Triptherapy has no verified rating, 0 comments, 104 favorites, and 111 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate Replika first
Put Replika on the priority trial list when the task aligns with “メンタルヘルス” and especially 自己啓発、バーチャルコンパニオン、AIコンパニオン、AI関係、対話型AI、孤独, or the users include クリエイティブ・プロフェッショナル、起業家、医療従事者、マーケティングマネージャー. This follows recorded positioning and does not imply unlisted capabilities are absent.
Replika also currently records: pricing is freemium, product type is app, 87.4K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate Triptherapy first
Put Triptherapy on the priority trial list when the task aligns with “メンタルヘルス” and especially 個人のウェルビーイング、AIセラピー、匿名チャット、ストレス管理, or the users include コンテンツクリエイター、プロダクトマネージャー、営業担当者. This follows recorded positioning and does not imply unlisted capabilities are absent.
Triptherapy also currently records: pricing is freemium, product type is website, 3.5K on-site monthly views, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in Replika and Triptherapy, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.




